accountBiotie's phase IIb study of tozadenant to treat Parkinson's disease meets ... pharmabiz.com These results suggest that tozadenant promises to be a useful treatment for Parkinson's disease patients experiencing wearing off fluctuations on levodopa." Dr Karl Kieburtz, Professor of Neurology, Environmental Medicine, and Community & Preventive ...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Biotie's phase IIb study of tozadenant to treat Parkinson's disease meets ... - pharmabiz.com
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account